-

Scott+Scott Attorneys at Law LLP Announces Investigation into Frequency Therapeutics, Inc. (FREQ)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, is investigating whether Frequency Therapeutics, Inc. (“Frequency” or the “Company”) (NASDAQ: FREQ), or certain of its officers and directors, violated federal securities laws. If you purchased Frequency common stock and recently suffered a loss, you are encouraged to contact Scott+Scott attorney Joe Pettigrew at 844-818-6982 or jpettigrew@scott-scott.com for more information.

Frequency is a clinical-stage biotechnology company. Its lead product candidate is FX-322, a potential treatment for hearing loss.

Our investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Frequency issued a press release on March 23, 2021, announcing topline data from its FX-322 Phase 2a study (FX-322-202). The Company admitted that “the interim results show that four weekly injections in subjects with mild to moderately severe sensorineural hearing loss (SNHL) did not demonstrate improvements in hearing measures versus placebo.”

On this news, Frequency’s stock price fell $28.30 per share – nearly 78% – to close at $7.99 per share on March 23, 2021.

What You Can Do

If you purchased Frequency common stock, and you wish to discuss this investigation, please contact attorney Joe Pettigrew at 844-818-6982, or at jpettigrew@scott-scott.com, or visit the Frequency investigation page on our website at https://scott-scott.com/investigation/frequency-therapeutics-inc/.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, Virginia, and Ohio.

Attorney Advertising

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, New York, NY 10169
844-818-6982
jpettigrew@scott-scott.com

Industry:

Scott+Scott Attorneys at Law LLP

NASDAQ:FREQ
Release Summary
Scott+Scott Attorneys at Law LLP Announces Investigation into Frequency Therapeutics, Inc. (FREQ)
Release Versions
English
Hashtags
#FREQ
#Frequency

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, New York, NY 10169
844-818-6982
jpettigrew@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

CAL-MAINE FOODS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Cal-Maine Foods, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CALM

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Cal-Maine Foods, Inc. (NASDAQ: CALM) failed to manage Cal-Maine Foods in an acceptable manner, breaching their fiduciary duties to Cal-Maine Foods, and whether Cal-Maine Foods and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On April 17, 2026, the Wall Stree...

SELECT MEDICAL HOLDINGS CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Select Medical Holdings Corporation’s Directors and Officers for Breach of Fiduciary Duties – SEM

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Select Medical Holdings Corporation (NYSE: SEM) approved a buyout of Select Medical Holdings for inadequate consideration, breaching their fiduciary duties to Select Medical Holdings’s shareholders, and whether Select Medical Holdings’s shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareho...

THE GEO GROUP, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates The GEO Group, Inc.’s Directors and Officers for Breach of Fiduciary Duties – GEO

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of The GEO Group, Inc. (NYSE: GEO) failed to manage The GEO Group in an acceptable manner, breaching their fiduciary duties to The GEO Group, and whether The GEO Group and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: The GEO Group has a long history of exposing...
Back to Newsroom